Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a report by the French Belgian Swiss APL group (APL 2006 trial)
暂无分享,去创建一个
S. Chevret | P. Fenaux | L. Adès | X. Thomas | N. Vey | G. Damaj | E. Raffoux | A. Pigneux | J. Marolleau | J. Lejeune | D. Bordessoule | O. Spertini | S. Wittnebel | Ramy Rahmé | S. Castaigne | A. Guerci-Bresler | R. Rahmé